| Name | Title | Contact Details |
|---|
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
PROLX Pharmaceuticals Corp is a Tucson, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AXM Pharma, Inc. is a global pharmaceutical company engaged in the production, marketing and distribution of pharmaceutical products in China. The Company produces, markets and distributes medicines in various dosages and forms in areas of medicinal
Aclario is a Vienna, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Harold Crossley is a Cockeysville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.